🔎 Trials Near Me

홈 › 방광암 › 아칸소

아칸소의 방광암 임상 시험

방광암 관련 연구 15개가 아칸소 내 여러 지역에서 참여자를 모집하고 있습니다.

아칸소의 도시

공식 연구 텍스트(영어)

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

  • Highlands Oncology Group - Fayetteville, Fayetteville
  • Highlands Oncology Group - Rogers, Rogers
  • Highlands Oncology Group, Springdale
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT07061964

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

  • Highlands Oncology Group - Fayetteville, Fayetteville
  • Highlands Oncology Group - Rogers, Rogers
  • Highlands Oncology Group, Springdale
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06770582

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

  • Highlands Oncology Group, PA, Fayetteville
  • Highlands Oncology Group, PA, Rogers
  • Highlands Oncology Group, PA, Springdale
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07421700

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

  • University of Arkansas for Medical Sciences, Little Rock
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07218380

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

  • University of Arkansas for Medical Sciences, Little Rock
  • Arkansas Urology, Little Rock
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06567743

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Mercy Hospital Fort Smith, Fort Smith
  • CARTI Cancer Center, Little Rock
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05334069

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

  • Arkansas Urology, Little Rock
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT05951179

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

  • Arkansas Urology, Little Rock
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT07480356

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

  • Mercy Hospital Fort Smith, Fort Smith
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT07097142

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

  • Arkansas Urology, Little Rock
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT04752722

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

  • Research Site, Hot Springs
  • Research Site, Little Rock
  • Research Site, Little Rock
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 7. 22. 업데이트됨 · NCT07720284

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

  • Highlands Oncology Group, Fayetteville
  • Highlands Oncology Group, Rogers
  • Highlands Oncology Group, Springdale
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT04389632

Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)

  • Mercy Hospital - FTS, Fort Smith
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT07327489

Clinical Evaluation of BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

  • Arkansas Urology Research Center, Little Rock
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 4. 23. 업데이트됨 · NCT05982561

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Little Rock
피험자 모집 중관찰 연구
전 연령 · 모든 성별 · 2025. 10. 28. 업데이트됨 · NCT03452774

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.